Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A randomized controlled pilot trial of etanercept and alpha-1 antitrypsin to improve autologous islet engraftment

Pancreatology(2022)10.1016/j.pan.2022.11.006Source: DataRank Database

A randomized controlled pilot trial of etanercept and alpha-1 antitrypsin to improve autologous islet engraftment is a research paper published in Pancreatology (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.47)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

James S. Hodges ORCID,Timothy L. Pruett ORCID,Karthik Ramanathan ORCID,Bernhard J. Hering ORCID,Ty B. Dunn ORCID

Live enrichment

PubMed:36443174 PMC:PMC9839597 OpenAlex:https://openalex.org/W4310061105

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01DK109914

National Center for Advancing Translational Sciences

Grant: UL1TR002494

NIDDK NIH HHS

Grant: T32 DK065519

National Institutes of Health

FWCI

1.47

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9839597

publisherhttps://api.elsevier.com/content/article/PII:S1424390322007955?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1424390322007955?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.pan.2022.11.006

Fields of Study

Pancreatic function and diabetesNeuropeptides and Animal PhysiologyDiabetes and associated disordersFemaleHumansMaleDiabetes MellitusEtanerceptGlucoseInsulinIslets of Langerhans TransplantationPancreatectomyPancreatitis, ChronicPilot ProjectsTransplantation, AutologousTreatment OutcomeThymalfasin

MeSH Terms

EtanerceptThymalfasinDiabetes MellitusFemaleGlucoseHumansInsulinMalePancreatectomyPilot ProjectsTransplantation, AutologousIslets of Langerhans TransplantationTreatment OutcomePancreatitis, Chronic

Keywords

MedicineIsletEtanerceptInsulinRandomized controlled trialInternal medicineTransplantationEndocrinologyTumor necrosis factor alphaCytokinesDiabetesChronic pancreatitisIslet AutotransplantationTpiat

Sustainable Development Goals

SDG 0: Good health and well-being